What is the right amount to spend on biopharma R & D?
Nature Reviews Drug Discovery 16, 597 (2017).
doi:10.1038/nrd.2017.114
Author: Michael S. Ringel
This analysis investigates whether some companies may be negatively affecting their overall commercial success by aiming to maintain steady earnings per share growth and/or a target ratio of R&D spending to sales.
Source: Nature Reviews Drug Discovery - Category: Drugs & Pharmacology Authors: Michael S. Ringel Tags: News and Analysis Source Type: research
More News: Drugs & Pharmacology